Direction - Read the passage and answer the questions that follow.

The Ministry of Railways has written to the Department for Promotion of Industry & Internal Trade, Ministry of Commerce and Industry, seeking exemption for procuring certain medical items manufactured outside India, particularly medicines used in the treatment of COVID-19, cancer, etc.The issue was first flagged in August 2020 by Northern Railway, which formally wrote to the Railway Board, expressing difficulty in procuring drugs and surgical items in the light of the latest ‘Make in India’ policy. It said that certain drugs used in cancer treatment were manufactured outside India but available in the Indian market through agents or dealers. Besides a surgical implant, the letter said that suppliers of anti-viral medicines used for the treatment of COVID-19, and even the vaccine for the coronavirus, may not fall under the Class-I or Class-II categories, which is required for purchases under the new ‘Make in India’ guidelines.Going by the Department for Promotion of Industry and Internal Trade’s (DPIIT) norms, Class-I is a local supplier or service provider whose goods, services or works offered for procurement have local content equal to or more than 50%, while Class-II is a supplier or service provider whose goods, services or works offered for procurement have local content of more than 20% but less than 50%